Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
L
290650
vs
K
KOSPI 200
Over the past 12 months, L&C Bio Co Ltd has underperformed KOSPI 200, delivering a return of +8% compared to KOSPI 200's +119% growth.
Stocks Performance
290650 vs KOSPI 200
Performance Gap
290650 vs KOSPI 200
Performance By Year
290650 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
L&C Bio Co Ltd
Glance View
L&C Bio Co Ltd makes and sells bio-based materials used mainly in cosmetics, medicine, and health products. Its core business is building ingredients and finished products around things like hyaluronic acid and other skin-care or medical-use raw materials. In simple terms, it sits in the middle of the value chain: it turns biological materials into products that other companies use or sell under their own brands. The company sells to cosmetic makers, medical product companies, and other business customers that need specialized raw materials or finished formulations. It also serves end customers through products that support skin care, wound care, or similar health and beauty uses. L&C Bio makes money by selling these ingredients and products, as well as by supplying customized materials and related manufacturing services. What makes its business model different is that it is not just a consumer brand company or a pure drug maker. It focuses on technical bio-materials and formulation know-how, which gives it a role as a supplier to larger downstream companies. That makes its revenue tied to demand for specialty ingredients and medical or cosmetic applications rather than to one single branded product line.